ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
84 hedge funds and large institutions have $79.1M invested in Zynerba Pharmaceuticals, Inc in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less capital invested
Capital invested by funds: $115M → $79.1M (-$36.2M)
Holders
84
Holding in Top 10
–
Calls
$6.27M
Puts
$6.32M
Top Buyers
| 1 | +$3.34M | |
| 2 | +$1.69M | |
| 3 | +$1.63M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.14M |
Top Sellers
| 1 | -$500K | |
| 2 | -$348K | |
| 3 | -$167K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$161K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$153K |